"The HemOnc Pulse" Live: Dr. Nowakowski Reflects on the Hodgkin Lymphoma Panel

"The HemOnc Pulse" Live: Dr. Nowakowski Reflects on the Hodgkin Lymphoma PanelПодробнее

'The HemOnc Pulse' Live: Summarizing the Unmet Needs in CLLПодробнее

'The HemOnc Pulse' Live: What Research is Needed in CML?Подробнее

Incorporating immunotherapy in the frontline & salvage treatment of Hodgkin lymphomaПодробнее

New findings and challenges in the use of immunotherapy in Hodgkin lymphomaПодробнее

The use of end-of-treatment PET in early-stage Hodgkin lymphomaПодробнее

Updates on the management of Hodgkin lymphoma: early-stage disease vs advanced stage diseaseПодробнее

Introducing The HemOnc Pulse hosted by Chadi Nabhan, MD, MBA, FACPПодробнее

The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in MyelomaПодробнее

The HemOnc Pulse Live at ASH: Tycel Phillips, MD, on the TRIANGLE Study, Frontline Therapy in MCLПодробнее

The current Hodgkin lymphoma immunotherapy landscapeПодробнее

Are biomarkers the future in Non-Hodgkin Lymphoma?Подробнее

Dr. Nowakowski on Using Patient Performance Score and Age for MCL TreatmentПодробнее

What’s current and what’s next in Hodgkin lymphoma?Подробнее

Concurrent pembrolizumab and chemotherapy in classical Hodgkin lymphomaПодробнее

Dr. Nowakowski on the Potential Role of Immunotherapy in MCLПодробнее

Survival gap between adult and pediatric cases of Hodgkin lymphomaПодробнее

Improving outcomes in Hodgkin lymphomaПодробнее

Novel immunotherapy combinations in Hodgkin lymphomaПодробнее